Tissue samples collected from patients with breast cancer during treatment may help explore therapy selection and predict toxicities.
Adriana Kahn, MD
Advertisement
Articles by Adriana Kahn, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC
2
FDA Grants Regular Approval to Rucaparib in Metastatic CRPC
3
Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer
4
All-Oral Elacestrant Combos Offer “Tremendous” Benefits in Breast Cancer
5